Consejo Interinstitucional de Ciencia y Tecnología ALI91-0486
-
July 25, 2017 (v1)PublicationUploaded on: December 4, 2022
-
January 30, 2024 (v1)Publication
The efficacy of resveratrol and some glucosyl, glucosylacyl, and glucuronide derivatives in inhibiting the adhesion of Salmonella Typhimurium, Escherichia coli O157:H7, and Listeria monocytogenes Scott A to Caco-2 and HT-29 colonic cells was investigated. The three bacteria strains were capable of adhering to both colonic epithelial cell lines,...
Uploaded on: February 4, 2024 -
January 30, 2024 (v1)Publication
There is no pharmaceutical or definitive surgical cure for inflammatory bowel diseases (IBDs). The naturally occurring polyphenol resveratrol exerts anti-inflammatory properties. However, its rapid metabolism diminishes its effectiveness in the colon. The design of prodrugs to targeting active molecules to the colon provides an opportunity for...
Uploaded on: February 4, 2024